Ducommun Inc
NYSE:DCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ducommun Inc
NYSE:DCO
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
B
|
BridgeBio Pharma Inc
XBER:2CL
|
US |
|
C
|
Celcuity Inc
NASDAQ:CELC
|
US |
|
Chemometec A/S
CSE:CHEMM
|
DK |
|
LG Display Co Ltd
KRX:034220
|
KR |
|
Iberdrola SA
F:IBE1
|
ES |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
V
|
Vivendi SE
XMUN:VVU
|
FR |
|
Nouveau Monde Graphite Inc
TSX:NOU
|
CA |
|
Hong Leong Asia Ltd
SGX:H22
|
SG |
|
H
|
Hexatronic Group AB
DUS:02H0
|
SE |
Wall St Price Targets
DCO Price Targets Summary
Ducommun Inc
According to Wall Street analysts, the average 1-year price target for DCO is 167.28 USD with a low forecast of 151.5 USD and a high forecast of 196.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DCO's stock price target?
Price Target
167.28
USD
According to Wall Street analysts, the average 1-year price target for DCO is 167.28 USD with a low forecast of 151.5 USD and a high forecast of 196.35 USD.
What is the Revenue forecast for Ducommun Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Ducommun Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Ducommun Inc?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 19%.
